What’s new

• GPCB orders closure of Aarti's Saykha amines unit within 15 days for water pollution non-compliance.
• The unit produces methylamine, a key raw material for drug manufacturing, and was recently commissioned.
• Company says no immediate financial impact, taking corrective steps; other plants unaffected.

Why it matters

The Saykha amines unit is a strategically important backward integration project expected to improve margins. Prolonged disruption could hit profitability and investor sentiment, even if near-term financial impact is denied.

What we’re watching

• Whether Aarti can resolve GPCB compliance and get the order revoked.
• If closure extends, potential supply chain impact for raw material.
• Any quantified financial impact if disruption prolongs.

The full read

Aarti Drugs' backward integration plan hit a roadblock as the Gujarat Pollution Control Board ordered closure of its Saykha amines unit within 15 days, citing water pollution non-compliance. The unit produces methylamine, a key raw material for drug manufacturing, and was commissioned earlier this year to improve margins. The company says there is no immediate financial impact and other plants are unaffected, but a prolonged shutdown could disrupt raw material supply and margin improvement. With trailing PAT down 12%, the regulatory action adds uncertainty to a stock trading at a trailing P/E of 17.4. The next test is whether Aarti can secure a revocation quickly.

Primary source: BSE · NSE